Advanced Wound Care Market By Product (Infection Management, Exudate Management, Active Wound Care, Therapy Devices), By Application (Chronic Wounds, Acute Wounds), By End User (Hospitals, Homecare Settings, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
The advanced wound care market was valued at $10.3 billion in 2022, and is estimated to reach $17.8 billion by 2032, exhibiting a CAGR of 5.6% from 2023 to 2032. Advanced wound care is a specialized and comprehensive approach to manage and treat complex and non-healing wounds. It involves the utilization of innovative wound care products, techniques and technologies that surpass traditional wound care methods, with the objective of promoting more rapid and effective wound healing. This encompassing approach is especially critical for addressing the unique challenges presented by chronic wounds, surgical wounds, burns, traumatic injuries and other intricate wound types. It includes a wide range of interventions, such as specialized wound dressings, biological and bioactive dressings, negative pressure wound therapy and the use of growth factors and cytokines to stimulate tissue repair. Advanced wound care aims to create an optimal wound healing environment, reduce infection risks, improve patient comfort and enhance overall outcomes. It is highly individualized, tailored to the specific needs of the patient and the characteristics of the wound, minimizing complications and ultimately improving the quality of life for those affected by challenging wounds.
The major factors driving the growth of the advanced wound care market include increase in prevalence of chronic wounds, availability of various advanced wound care products and rise in awareness related to advanced wound care among healthcare providers and patients. Chronic wounds, including diabetic ulcers, venous leg ulcers and pressure ulcers, represent a substantial healthcare challenge. For instance, article published by Mary Ann Liebert, Inc., in 2021, stated that, 2% of the total U.S. population are estimated to be affected by chronic wounds. The incidence of chronic wounds is rising owing to several factors such as aging population, increase in chronic diseases such as diabetes and obesity, and other factors. In addition, with the aging global population, there are higher chances of chronic wounds. Older individuals are more susceptible to these types of wounds owing to age-related skin changes, reduced tissue elasticity and slower healing processes.
Furthermore, the prevalence of chronic diseases is on the rise worldwide. Conditions such as diabetes, obesity and cardiovascular diseases often lead to chronic wounds as complications. For instance, diabetes can cause diabetic foot ulcers, which can be challenging to manage and heal. In addition, prolonged hospitalizations are common among patients with chronic illnesses. Extended stays in hospitals or long-term care facilities increase the risk of developing pressure ulcers and other healthcare-associated wounds, further contributing to the demand for advanced wound care products. Moreover, the availability of various advanced wound care products is a crucial factor propelling the market growth. The availability of a wide range of innovative wound care products designed to address the unique challenges of different wound types is expected to drive the market growth. These products offer solutions that go beyond traditional wound care, enabling healthcare providers to provide more effective treatments. Specialized wound dressings are a key category of advanced wound care products. These dressings, include foam dressings, hydrocolloids, hydrogels and alginate dressings, designed for specific wound types, creating an optimal environment for healing and promoting faster tissue repair.
In addition, biological and bioactive dressings, such as bioactive dressings and skin substitutes, contain growth factors and other biologically active substances that enhance tissue regeneration, making them invaluable for the management of chronic and complex wounds. Negative pressure wound therapy (NPWT) is another advanced technique that applies controlled negative pressure to the wound through a vacuum-sealed dressings. This method effectively reduces excess fluid, minimizes swelling and boosts blood flow to the wound, expediting the healing process. Thus, availability of such advanced wound care products is anticipated to drive the market growth.
The advanced wound care market is segmented into product, application, end user and region. On the basis of product, the market is categorized into infection management, exudate management, active wound care and therapy devices. The infection management segment is further divided into silver wound dressings, non-silver dressings and collagen dressings. The exudate management segment is divided into hydrocolloids dressings, foam dressings, alginate dressings and hydrogel dressings. The active wound care segment is divided into Skin Substitutes and growth factors. The therapy devices segment is further bifurcated into negative pressure wound therapy (NPWT), oxygen and hyperbaric oxygen equipment, electromagnetic therapy devices and others.
Based on application, the market is categorized into chronic and acute wounds. The chronic wound segment is further segmented into pressure ulcers, diabetic foot ulcers, venous leg ulcers and arterial ulcers. The acute wound segment is further divided into burns & trauma and surgical wounds. On the basis of end user, the market is segregated into hospital, homecare settings and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). Major key players that operate in the global advanced wound care market include ConvaTec Group plc, 3M Company, Cardinal Health Inc., Organogenesis Holdings Inc., Smith & Nephew plc., B. Braun SE, Coloplast, Integra LifeSciences Holdings Corporation, Molnlycke Health Care AB and MIMEDX Group, Inc. The key players have adopted strategies such as acquisition, contract, expansion, product upgrade, funding, product launch and product approval to expand their product portfolio.
Key Benefits for Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the advanced wound care market analysis from 2022 to 2032 to identify the prevailing advanced wound care market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the advanced wound care market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global advanced wound care market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By End User
Hospitals
Homecare Settings
Others
By Product
Infection Management
Type
Silver Wound Dressings
Non-Silver Dressings
Collagen Dressings
Exudate Management
Type
Hydrocolloids Dressings
Foam Dressings
Alginate Dressings
Hydrogel Dressings
Active Wound Care
Type
Skin Substitutes
Growth Factors
Therapy Devices
Type
Negative Pressure Wound Therapy (NPWT)
Oxygen and Hyperbaric Oxygen Equipment
Electromagnetic Therapy Devices
Others
By Application
Acute Wounds
Type
Burns and Trauma
Surgical Wounds
Chronic Wounds
Type
Pressure Ulcers
Diabetic Foot Ulcers
Venous Leg Ulcers
Arterial Ulcers
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Smith & Nephew plc
3M Company
B. Braun SE
Integra LifeSciences Holdings Corporation
Cardinal Health Inc.
MIMEDX Group, Inc.
Molnlycke Health Care AB
Coloplast
ConvaTec Group plc
ORGANOGENESIS HOLDINGS INC.
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1: INTRODUCTION
- 1.1. Report description
- 1.2. Key market segments
- 1.3. Key benefits to the stakeholders
- 1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET OVERVIEW
- 3.1. Market definition and scope
- 3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
- 3.3. Porter’s five forces analysis
- 3.3.1. High bargaining power of suppliers
- 3.3.2. Moderate threat of new entrants
- 3.3.3. Moderate threat of substitutes
- 3.3.4. Moderate intensity of rivalry
- 3.3.5. High bargaining power of buyers
- 3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.1.1. Increase in prevalence of diabetes, obesity, and chronic conditions
- 3.4.1.2. Technological advancements in wound care management
- 3.4.1.3. Rise in new product launches for wound care treatment
- 3.4.2. Restraints
- 3.4.2.1. Stringent regulations for manufacturing of wound care products
- 3.4.3. Opportunities
- 3.4.3.1. Growing opportunity in emerging markets
- CHAPTER 4: ADVANCED WOUND CARE MARKET, BY PRODUCT
- 4.1. Overview
- 4.1.1. Market size and forecast
- 4.2. Infection Management
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.2.4. Infection Management Advanced Wound Care Market by Type
- 4.3. Exudate Management
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
- 4.3.4. Exudate Management Advanced Wound Care Market by Type
- 4.4. Active Wound Care
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country
- 4.4.4. Active Wound Care Advanced Wound Care Market by Type
- 4.5. Therapy Devices
- 4.5.1. Key market trends, growth factors and opportunities
- 4.5.2. Market size and forecast, by region
- 4.5.3. Market share analysis by country
- 4.5.4. Therapy Devices Advanced Wound Care Market by Type
- CHAPTER 5: ADVANCED WOUND CARE MARKET, BY APPLICATION
- 5.1. Overview
- 5.1.1. Market size and forecast
- 5.2. Chronic Wounds
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
- 5.2.4. Chronic Wounds Advanced Wound Care Market by Type
- 5.3. Acute Wounds
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
- 5.3.4. Acute Wounds Advanced Wound Care Market by Type
- CHAPTER 6: ADVANCED WOUND CARE MARKET, BY END USER
- 6.1. Overview
- 6.1.1. Market size and forecast
- 6.2. Hospitals
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
- 6.3. Homecare Settings
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
- 6.4. Others
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country
- CHAPTER 7: ADVANCED WOUND CARE MARKET, BY REGION
- 7.1. Overview
- 7.1.1. Market size and forecast By Region
- 7.2. North America
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by Product
- 7.2.3. Market size and forecast, by Application
- 7.2.4. Market size and forecast, by End User
- 7.2.5. Market size and forecast, by country
- 7.2.5.1. U.S.
- 7.2.5.1.1. Market size and forecast, by Product
- 7.2.5.1.2. Market size and forecast, by Application
- 7.2.5.1.3. Market size and forecast, by End User
- 7.2.5.2. Canada
- 7.2.5.2.1. Market size and forecast, by Product
- 7.2.5.2.2. Market size and forecast, by Application
- 7.2.5.2.3. Market size and forecast, by End User
- 7.2.5.3. Mexico
- 7.2.5.3.1. Market size and forecast, by Product
- 7.2.5.3.2. Market size and forecast, by Application
- 7.2.5.3.3. Market size and forecast, by End User
- 7.3. Europe
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by Product
- 7.3.3. Market size and forecast, by Application
- 7.3.4. Market size and forecast, by End User
- 7.3.5. Market size and forecast, by country
- 7.3.5.1. Germany
- 7.3.5.1.1. Market size and forecast, by Product
- 7.3.5.1.2. Market size and forecast, by Application
- 7.3.5.1.3. Market size and forecast, by End User
- 7.3.5.2. France
- 7.3.5.2.1. Market size and forecast, by Product
- 7.3.5.2.2. Market size and forecast, by Application
- 7.3.5.2.3. Market size and forecast, by End User
- 7.3.5.3. UK
- 7.3.5.3.1. Market size and forecast, by Product
- 7.3.5.3.2. Market size and forecast, by Application
- 7.3.5.3.3. Market size and forecast, by End User
- 7.3.5.4. Italy
- 7.3.5.4.1. Market size and forecast, by Product
- 7.3.5.4.2. Market size and forecast, by Application
- 7.3.5.4.3. Market size and forecast, by End User
- 7.3.5.5. Spain
- 7.3.5.5.1. Market size and forecast, by Product
- 7.3.5.5.2. Market size and forecast, by Application
- 7.3.5.5.3. Market size and forecast, by End User
- 7.3.5.6. Rest of Europe
- 7.3.5.6.1. Market size and forecast, by Product
- 7.3.5.6.2. Market size and forecast, by Application
- 7.3.5.6.3. Market size and forecast, by End User
- 7.4. Asia-Pacific
- 7.4.1. Key market trends, growth factors and opportunities
- 7.4.2. Market size and forecast, by Product
- 7.4.3. Market size and forecast, by Application
- 7.4.4. Market size and forecast, by End User
- 7.4.5. Market size and forecast, by country
- 7.4.5.1. Japan
- 7.4.5.1.1. Market size and forecast, by Product
- 7.4.5.1.2. Market size and forecast, by Application
- 7.4.5.1.3. Market size and forecast, by End User
- 7.4.5.2. China
- 7.4.5.2.1. Market size and forecast, by Product
- 7.4.5.2.2. Market size and forecast, by Application
- 7.4.5.2.3. Market size and forecast, by End User
- 7.4.5.3. India
- 7.4.5.3.1. Market size and forecast, by Product
- 7.4.5.3.2. Market size and forecast, by Application
- 7.4.5.3.3. Market size and forecast, by End User
- 7.4.5.4. Australia
- 7.4.5.4.1. Market size and forecast, by Product
- 7.4.5.4.2. Market size and forecast, by Application
- 7.4.5.4.3. Market size and forecast, by End User
- 7.4.5.5. South Korea
- 7.4.5.5.1. Market size and forecast, by Product
- 7.4.5.5.2. Market size and forecast, by Application
- 7.4.5.5.3. Market size and forecast, by End User
- 7.4.5.6. Rest of Asia-Pacific
- 7.4.5.6.1. Market size and forecast, by Product
- 7.4.5.6.2. Market size and forecast, by Application
- 7.4.5.6.3. Market size and forecast, by End User
- 7.5. LAMEA
- 7.5.1. Key market trends, growth factors and opportunities
- 7.5.2. Market size and forecast, by Product
- 7.5.3. Market size and forecast, by Application
- 7.5.4. Market size and forecast, by End User
- 7.5.5. Market size and forecast, by country
- 7.5.5.1. Brazil
- 7.5.5.1.1. Market size and forecast, by Product
- 7.5.5.1.2. Market size and forecast, by Application
- 7.5.5.1.3. Market size and forecast, by End User
- 7.5.5.2. Saudi Arabia
- 7.5.5.2.1. Market size and forecast, by Product
- 7.5.5.2.2. Market size and forecast, by Application
- 7.5.5.2.3. Market size and forecast, by End User
- 7.5.5.3. South Africa
- 7.5.5.3.1. Market size and forecast, by Product
- 7.5.5.3.2. Market size and forecast, by Application
- 7.5.5.3.3. Market size and forecast, by End User
- 7.5.5.4. Rest of LAMEA
- 7.5.5.4.1. Market size and forecast, by Product
- 7.5.5.4.2. Market size and forecast, by Application
- 7.5.5.4.3. Market size and forecast, by End User
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product mapping of top 10 player
- 8.4. Competitive dashboard
- 8.5. Competitive heatmap
- 8.6. Top player positioning, 2022
- CHAPTER 9: COMPANY PROFILES
- 9.1. Smith & Nephew plc
- 9.1.1. Company overview
- 9.1.2. Key executives
- 9.1.3. Company snapshot
- 9.1.4. Operating business segments
- 9.1.5. Product portfolio
- 9.1.6. Business performance
- 9.1.7. Key strategic moves and developments
- 9.2. 3M Company
- 9.2.1. Company overview
- 9.2.2. Key executives
- 9.2.3. Company snapshot
- 9.2.4. Operating business segments
- 9.2.5. Product portfolio
- 9.2.6. Business performance
- 9.2.7. Key strategic moves and developments
- 9.3. Molnlycke Health Care AB
- 9.3.1. Company overview
- 9.3.2. Key executives
- 9.3.3. Company snapshot
- 9.3.4. Operating business segments
- 9.3.5. Product portfolio
- 9.3.6. Business performance
- 9.3.7. Key strategic moves and developments
- 9.4. ORGANOGENESIS HOLDINGS INC.
- 9.4.1. Company overview
- 9.4.2. Key executives
- 9.4.3. Company snapshot
- 9.4.4. Operating business segments
- 9.4.5. Product portfolio
- 9.4.6. Business performance
- 9.4.7. Key strategic moves and developments
- 9.5. B. Braun SE
- 9.5.1. Company overview
- 9.5.2. Key executives
- 9.5.3. Company snapshot
- 9.5.4. Operating business segments
- 9.5.5. Product portfolio
- 9.5.6. Business performance
- 9.6. Coloplast
- 9.6.1. Company overview
- 9.6.2. Key executives
- 9.6.3. Company snapshot
- 9.6.4. Operating business segments
- 9.6.5. Product portfolio
- 9.6.6. Business performance
- 9.6.7. Key strategic moves and developments
- 9.7. Integra LifeSciences Holdings Corporation
- 9.7.1. Company overview
- 9.7.2. Key executives
- 9.7.3. Company snapshot
- 9.7.4. Operating business segments
- 9.7.5. Product portfolio
- 9.7.6. Business performance
- 9.8. MIMEDX Group, Inc.
- 9.8.1. Company overview
- 9.8.2. Key executives
- 9.8.3. Company snapshot
- 9.8.4. Operating business segments
- 9.8.5. Product portfolio
- 9.8.6. Business performance
- 9.8.7. Key strategic moves and developments
- 9.9. Cardinal Health Inc.
- 9.9.1. Company overview
- 9.9.2. Key executives
- 9.9.3. Company snapshot
- 9.9.4. Operating business segments
- 9.9.5. Product portfolio
- 9.9.6. Business performance
- 9.10. ConvaTec Group plc
- 9.10.1. Company overview
- 9.10.2. Key executives
- 9.10.3. Company snapshot
- 9.10.4. Operating business segments
- 9.10.5. Product portfolio
- 9.10.6. Business performance
- 9.10.7. Key strategic moves and developments
- LIST OF TABLES
- TABLE 01. GLOBAL ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 02. ADVANCED WOUND CARE MARKET FOR INFECTION MANAGEMENT, BY REGION, 2022-2032 ($MILLION)
- TABLE 03. GLOBAL INFECTION MANAGEMENT ADVANCED WOUND CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 04. ADVANCED WOUND CARE MARKET FOR EXUDATE MANAGEMENT, BY REGION, 2022-2032 ($MILLION)
- TABLE 05. GLOBAL EXUDATE MANAGEMENT ADVANCED WOUND CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 06. ADVANCED WOUND CARE MARKET FOR ACTIVE WOUND CARE, BY REGION, 2022-2032 ($MILLION)
- TABLE 07. GLOBAL ACTIVE WOUND CARE ADVANCED WOUND CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 08. ADVANCED WOUND CARE MARKET FOR THERAPY DEVICES, BY REGION, 2022-2032 ($MILLION)
- TABLE 09. GLOBAL THERAPY DEVICES ADVANCED WOUND CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 10. GLOBAL ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 11. ADVANCED WOUND CARE MARKET FOR CHRONIC WOUNDS, BY REGION, 2022-2032 ($MILLION)
- TABLE 12. GLOBAL CHRONIC WOUNDS ADVANCED WOUND CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 13. ADVANCED WOUND CARE MARKET FOR ACUTE WOUNDS, BY REGION, 2022-2032 ($MILLION)
- TABLE 14. GLOBAL ACUTE WOUNDS ADVANCED WOUND CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 15. GLOBAL ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 16. ADVANCED WOUND CARE MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
- TABLE 17. ADVANCED WOUND CARE MARKET FOR HOMECARE SETTINGS, BY REGION, 2022-2032 ($MILLION)
- TABLE 18. ADVANCED WOUND CARE MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
- TABLE 19. ADVANCED WOUND CARE MARKET, BY REGION, 2022-2032 ($MILLION)
- TABLE 20. NORTH AMERICA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 21. NORTH AMERICA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 22. NORTH AMERICA ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 23. NORTH AMERICA ADVANCED WOUND CARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 24. U.S. ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 25. U.S. ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 26. U.S. ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 27. CANADA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 28. CANADA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 29. CANADA ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 30. MEXICO ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 31. MEXICO ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 32. MEXICO ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 33. EUROPE ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 34. EUROPE ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 35. EUROPE ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 36. EUROPE ADVANCED WOUND CARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 37. GERMANY ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 38. GERMANY ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 39. GERMANY ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 40. FRANCE ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 41. FRANCE ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 42. FRANCE ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 43. UK ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 44. UK ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 45. UK ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 46. ITALY ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 47. ITALY ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 48. ITALY ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 49. SPAIN ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 50. SPAIN ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 51. SPAIN ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 52. REST OF EUROPE ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 53. REST OF EUROPE ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 54. REST OF EUROPE ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 55. ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 56. ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 57. ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 58. ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 59. JAPAN ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 60. JAPAN ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 61. JAPAN ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 62. CHINA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 63. CHINA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 64. CHINA ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 65. INDIA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 66. INDIA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 67. INDIA ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 68. AUSTRALIA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 69. AUSTRALIA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 70. AUSTRALIA ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 71. SOUTH KOREA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 72. SOUTH KOREA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 73. SOUTH KOREA ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 74. REST OF ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 75. REST OF ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 76. REST OF ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 77. LAMEA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 78. LAMEA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 79. LAMEA ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 80. LAMEA ADVANCED WOUND CARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 81. BRAZIL ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 82. BRAZIL ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 83. BRAZIL ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 84. SAUDI ARABIA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 85. SAUDI ARABIA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 86. SAUDI ARABIA ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 87. SOUTH AFRICA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 88. SOUTH AFRICA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 89. SOUTH AFRICA ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 90. REST OF LAMEA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 91. REST OF LAMEA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 92. REST OF LAMEA ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 93. SMITH & NEPHEW PLC: KEY EXECUTIVES
- TABLE 94. SMITH & NEPHEW PLC: COMPANY SNAPSHOT
- TABLE 95. SMITH & NEPHEW PLC: PRODUCT SEGMENTS
- TABLE 96. SMITH & NEPHEW PLC: PRODUCT PORTFOLIO
- TABLE 97. SMITH & NEPHEW PLC: KEY STRATERGIES
- TABLE 98. 3M COMPANY: KEY EXECUTIVES
- TABLE 99. 3M COMPANY: COMPANY SNAPSHOT
- TABLE 100. 3M COMPANY: PRODUCT SEGMENTS
- TABLE 101. 3M COMPANY: PRODUCT PORTFOLIO
- TABLE 102. 3M COMPANY: KEY STRATERGIES
- TABLE 103. MOLNLYCKE HEALTH CARE AB: KEY EXECUTIVES
- TABLE 104. MOLNLYCKE HEALTH CARE AB: COMPANY SNAPSHOT
- TABLE 105. MOLNLYCKE HEALTH CARE AB: PRODUCT SEGMENTS
- TABLE 106. MOLNLYCKE HEALTH CARE AB: PRODUCT PORTFOLIO
- TABLE 107. MOLNLYCKE HEALTH CARE AB: KEY STRATERGIES
- TABLE 108. ORGANOGENESIS HOLDINGS INC.: KEY EXECUTIVES
- TABLE 109. ORGANOGENESIS HOLDINGS INC.: COMPANY SNAPSHOT
- TABLE 110. ORGANOGENESIS HOLDINGS INC.: PRODUCT SEGMENTS
- TABLE 111. ORGANOGENESIS HOLDINGS INC.: PRODUCT PORTFOLIO
- TABLE 112. ORGANOGENESIS HOLDINGS INC.: KEY STRATERGIES
- TABLE 113. B. BRAUN SE: KEY EXECUTIVES
- TABLE 114. B. BRAUN SE: COMPANY SNAPSHOT
- TABLE 115. B. BRAUN SE: PRODUCT SEGMENTS
- TABLE 116. B. BRAUN SE: PRODUCT PORTFOLIO
- TABLE 117. COLOPLAST: KEY EXECUTIVES
- TABLE 118. COLOPLAST: COMPANY SNAPSHOT
- TABLE 119. COLOPLAST: PRODUCT SEGMENTS
- TABLE 120. COLOPLAST: PRODUCT PORTFOLIO
- TABLE 121. COLOPLAST: KEY STRATERGIES
- TABLE 122. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: KEY EXECUTIVES
- TABLE 123. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT
- TABLE 124. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: PRODUCT SEGMENTS
- TABLE 125. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: PRODUCT PORTFOLIO
- TABLE 126. MIMEDX GROUP, INC.: KEY EXECUTIVES
- TABLE 127. MIMEDX GROUP, INC.: COMPANY SNAPSHOT
- TABLE 128. MIMEDX GROUP, INC.: PRODUCT SEGMENTS
- TABLE 129. MIMEDX GROUP, INC.: PRODUCT PORTFOLIO
- TABLE 130. MIMEDX GROUP, INC.: KEY STRATERGIES
- TABLE 131. CARDINAL HEALTH INC.: KEY EXECUTIVES
- TABLE 132. CARDINAL HEALTH INC.: COMPANY SNAPSHOT
- TABLE 133. CARDINAL HEALTH INC.: PRODUCT SEGMENTS
- TABLE 134. CARDINAL HEALTH INC.: PRODUCT PORTFOLIO
- TABLE 135. CONVATEC GROUP PLC: KEY EXECUTIVES
- TABLE 136. CONVATEC GROUP PLC: COMPANY SNAPSHOT
- TABLE 137. CONVATEC GROUP PLC: PRODUCT SEGMENTS
- TABLE 138. CONVATEC GROUP PLC: PRODUCT PORTFOLIO
- TABLE 139. CONVATEC GROUP PLC: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 01. ADVANCED WOUND CARE MARKET, 2022-2032
- FIGURE 02. SEGMENTATION OF ADVANCED WOUND CARE MARKET,2022-2032
- FIGURE 03. TOP IMPACTING FACTORS IN ADVANCED WOUND CARE MARKET (2022 TO 2032)
- FIGURE 04. TOP INVESTMENT POCKETS IN ADVANCED WOUND CARE MARKET (2023-2032)
- FIGURE 05. HIGH BARGAINING POWER OF SUPPLIERS
- FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 07. MODERATE THREAT OF SUBSTITUTES
- FIGURE 08. MODERATE INTENSITY OF RIVALRY
- FIGURE 09. HIGH BARGAINING POWER OF BUYERS
- FIGURE 10. GLOBAL ADVANCED WOUND CARE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 11. ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022 AND 2032(%)
- FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ADVANCED WOUND CARE MARKET FOR INFECTION MANAGEMENT, BY COUNTRY 2022 AND 2032(%)
- FIGURE 13. COMPARATIVE SHARE ANALYSIS OF ADVANCED WOUND CARE MARKET FOR EXUDATE MANAGEMENT, BY COUNTRY 2022 AND 2032(%)
- FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ADVANCED WOUND CARE MARKET FOR ACTIVE WOUND CARE, BY COUNTRY 2022 AND 2032(%)
- FIGURE 15. COMPARATIVE SHARE ANALYSIS OF ADVANCED WOUND CARE MARKET FOR THERAPY DEVICES, BY COUNTRY 2022 AND 2032(%)
- FIGURE 16. ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022 AND 2032(%)
- FIGURE 17. COMPARATIVE SHARE ANALYSIS OF ADVANCED WOUND CARE MARKET FOR CHRONIC WOUNDS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ADVANCED WOUND CARE MARKET FOR ACUTE WOUNDS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 19. ADVANCED WOUND CARE MARKET, BY END USER, 2022 AND 2032(%)
- FIGURE 20. COMPARATIVE SHARE ANALYSIS OF ADVANCED WOUND CARE MARKET FOR HOSPITALS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 21. COMPARATIVE SHARE ANALYSIS OF ADVANCED WOUND CARE MARKET FOR HOMECARE SETTINGS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 22. COMPARATIVE SHARE ANALYSIS OF ADVANCED WOUND CARE MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 23. ADVANCED WOUND CARE MARKET BY REGION, 2022 AND 2032(%)
- FIGURE 24. U.S. ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
- FIGURE 25. CANADA ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
- FIGURE 26. MEXICO ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
- FIGURE 27. GERMANY ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
- FIGURE 28. FRANCE ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
- FIGURE 29. UK ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
- FIGURE 30. ITALY ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
- FIGURE 31. SPAIN ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
- FIGURE 32. REST OF EUROPE ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
- FIGURE 33. JAPAN ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
- FIGURE 34. CHINA ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
- FIGURE 35. INDIA ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
- FIGURE 36. AUSTRALIA ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
- FIGURE 37. SOUTH KOREA ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
- FIGURE 38. REST OF ASIA-PACIFIC ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
- FIGURE 39. BRAZIL ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
- FIGURE 40. SAUDI ARABIA ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
- FIGURE 41. SOUTH AFRICA ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
- FIGURE 42. REST OF LAMEA ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
- FIGURE 43. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 44. COMPETITIVE DASHBOARD
- FIGURE 45. COMPETITIVE HEATMAP: ADVANCED WOUND CARE MARKET
- FIGURE 46. TOP PLAYER POSITIONING, 2022
- FIGURE 47. SMITH & NEPHEW PLC: NET REVENUE, 2020-2022 ($MILLION)
- FIGURE 48. SMITH & NEPHEW PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 49. SMITH & NEPHEW PLC: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 50. 3M COMPANY: NET REVENUE, 2020-2022 ($MILLION)
- FIGURE 51. 3M COMPANY: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
- FIGURE 52. 3M COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 53. 3M COMPANY: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 54. MOLNLYCKE HEALTH CARE AB: NET REVENUE, 2020-2022 ($MILLION)
- FIGURE 55. MOLNLYCKE HEALTH CARE AB: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 56. MOLNLYCKE HEALTH CARE AB: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 57. ORGANOGENESIS HOLDINGS INC.: NET REVENUE, 2020-2022 ($MILLION)
- FIGURE 58. B. BRAUN SE: NET REVENUE, 2020-2022 ($MILLION)
- FIGURE 59. B. BRAUN SE: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 60. B. BRAUN SE: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 61. COLOPLAST: NET REVENUE, 2020-2022 ($MILLION)
- FIGURE 62. COLOPLAST: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 63. COLOPLAST: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 64. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
- FIGURE 65. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 66. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 67. MIMEDX GROUP, INC.: NET SALES, 2020-2022 ($MILLION)
- FIGURE 68. CARDINAL HEALTH INC.: NET REVENUE, 2020-2022 ($MILLION)
- FIGURE 69. CARDINAL HEALTH INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 70. CARDINAL HEALTH INC.: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 71. CONVATEC GROUP PLC: NET REVENUE, 2020-2022 ($MILLION)
- FIGURE 72. CONVATEC GROUP PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 73. CONVATEC GROUP PLC: REVENUE SHARE BY REGION, 2022 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook